Paper28604752
Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells.
Feng J and 9 others. Oncogene, 2017. Cited by 370 papers, by iCite.
Cite this record
ConductScience Library. Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells. Papers, record 28604752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28604752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| B7-H1 Antigen | Major topic |
| Intracellular Signaling Peptides and Proteins | Major topic |
| Lactic Acid | Major topic |
| Lung Neoplasms | Major topic |
| Receptors, G-Protein-Coupled | Major topic |
| Apoptosis | |
| Cell Line, Tumor | |
| Cyclic AMP | |
| Cyclic AMP-Dependent Protein Kinases | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Interferon-gamma | |
| Jurkat Cells | |
| Lactate Dehydrogenases | |
| Signal Transduction | |
| T-Lymphocytes, Cytotoxic | |
| Trans-Activators | |
| Transcription Factors | |
| Transcriptional Activation | |
| Transcriptional Coactivator with PDZ-Binding Motif Proteins |
Source PubMed
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21862690 | Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functions. | Mol Pharmacol | 2011 | https://conductscience.org/library/papers/21862690 | PubMed |
| 2 | 25858804 | Immune checkpoint blockade: a common denominator approach to cancer therapy. | Cancer Cell | 2015 | https://conductscience.org/library/papers/25858804 | PubMed |
| 3 | 26967289 | The Basis of Oncoimmunology. | Cell | 2016 | https://conductscience.org/library/papers/26967289 | PubMed |
| 4 | 24336068 | A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. | Cancer Res | 2014 | https://conductscience.org/library/papers/24336068 | PubMed |
| 5 | 27079802 | Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27079802 | PubMed |
| 6 | 23752589 | Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. | Genes Dev | 2013 | https://conductscience.org/library/papers/23752589 | PubMed |
| 7 | 26805820 | The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis. | Int J Mol Sci | 2016 | https://conductscience.org/library/papers/26805820 | PubMed |
| 8 | 15254870 | Lactate: mirror and motor of tumor malignancy. | Semin Radiat Oncol | 2004 | https://conductscience.org/library/papers/15254870 | PubMed |
| 9 | 25452452 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25452452 | PubMed |
| 10 | 24380865 | The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity. | Biochem Biophys Res Commun | 2014 | https://conductscience.org/library/papers/24380865 | PubMed |
| 11 | 25774832 | Metabolic pathways promoting cancer cell survival and growth. | Nat Cell Biol | 2015 | https://conductscience.org/library/papers/25774832 | PubMed |
| 12 | 15279558 | Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. | Curr Med Chem | 2004 | https://conductscience.org/library/papers/15279558 | PubMed |
| 13 | 26273330 | Review of aerobic glycolysis and its key enzymes - new targets for lung cancer therapy. | Thorac Cancer | 2015 | https://conductscience.org/library/papers/26273330 | PubMed |
| 14 | 21258416 | TAZ is a novel oncogene in non-small cell lung cancer. | Oncogene | 2011 | https://conductscience.org/library/papers/21258416 | PubMed |
| 15 | 27300434 | YAP/TAZ at the Roots of Cancer. | Cancer Cell | 2016 | https://conductscience.org/library/papers/27300434 | PubMed |
| 16 | 17255361 | Inhibitory effect of tumor cell-derived lactic acid on human T cells. | Blood | 2007 | https://conductscience.org/library/papers/17255361 | PubMed |
| 17 | 24590637 | Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab. | J Clin Oncol | 2014 | https://conductscience.org/library/papers/24590637 | PubMed |
| 18 | 21300765 | Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. | Cancer Res | 2011 | https://conductscience.org/library/papers/21300765 | PubMed |
| 19 | 24928781 | Cell surface lactate receptor GPR81 is crucial for cancer cell survival. | Cancer Res | 2014 | https://conductscience.org/library/papers/24928781 | PubMed |
| 20 | 25891174 | Pembrolizumab for the treatment of non-small-cell lung cancer. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25891174 | PubMed |
Cited by284
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 370 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42903895 | Nanomaterials Reshaping Tumor Metabolism: A New Frontier to Overcome T Cell Exhaustion. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42903895 | PubMed |
| 42897554 | Lactylation in cancer: a new frontier in metabolic-epigenetic regulation and clinical practice. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42897554 | PubMed |
| 42864833 | Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non-Small Cell Lung Cancer: Mechanisms to Clinical Translation. | Cancer Med | 2026 | https://conductscience.org/library/papers/42864833 | PubMed |
| 42844248 | Glucose-induced histone lactylation confers metformin resistance in colorectal cancer stem cells. | Nat Commun | 2026 | https://conductscience.org/library/papers/42844248 | PubMed |
| 42839156 | A Comparison of Mechanisms Driving Lesion Outcomes During Lung Tumor and Tuberculosis Granuloma Formation. | Bull Math Biol | 2026 | https://conductscience.org/library/papers/42839156 | PubMed |
| 42751446 | The multifaceted functions of lactate and its translational potentials in cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42751446 | PubMed |
| 42684666 | Targeting MYC-Driven Cancers: From Oncogenic Addiction to Therapeutic Vulnerability. | BioDrugs | 2026 | https://conductscience.org/library/papers/42684666 | PubMed |
| 42658371 | Lactate metabolism and protein lactylation in inflammatory and tumor microenvironments. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42658371 | PubMed |
| 42650009 | Monocarboxylate Transporter 1 (MCT1) in Cancer Biology: Canonical Transport Functions, Metabolic-Epigenetic Crosstalk and Emerging Nuclear Localisation. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42650009 | PubMed |
| 42630682 | Dynamic Metabolic States in TNBC: Orchestrating Spatiotemporal Adaptation and Therapy. | Oncol Res | 2026 | https://conductscience.org/library/papers/42630682 | PubMed |
| 42543035 | Lactylation in influenza a virus infection: Current evidence, knowledge gaps, and future perspectives. | Virulence | 2026 | https://conductscience.org/library/papers/42543035 | PubMed |
| 42469825 | Glycolysis drives vascular hyperpermeability in acute lung injury via lactate-GPR81 axis in endothelial cells. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42469825 | PubMed |
| 42435175 | Influence of RNA Modifications on Cancer Metabolism: Interplay with Hypoxia and Therapeutic Implications. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/42435175 | PubMed |
| 42421972 | The lactate-lactylation axis in tumor radioresistance: metabolic, epigenetic, and immune mechanisms with emerging links to RNA regulation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42421972 | PubMed |
| 42387950 | PD-L1 Expression in Acute Myeloid Leukemia Cells: Associations With Cell Metabolism. | J Immunol Res | 2026 | https://conductscience.org/library/papers/42387950 | PubMed |
| 42382771 | Immune-tumor cell ligand-receptor axes driving metabolic reprogramming and therapeutic resistance in cancer. | Front Immunol | 2026 | https://conductscience.org/library/papers/42382771 | PubMed |
| 42359706 | Understanding the epigenetic regulation of lactylation and aberrant lactate metabolism in cancer: From mechanisms to therapeutic strategies (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42359706 | PubMed |
| 42359353 | Metabolic rewiring of the tumor microenvironment: therapeutic intervention of multi-pathway adaptations to impede cancer metastasis. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42359353 | PubMed |
| 42346101 | Determinants of Colorectal Cancer: An Integrative Immunometabolic Framework Linking Biomarkers, Therapy, and the Diet-Microbiota Axis. | Cells | 2026 | https://conductscience.org/library/papers/42346101 | PubMed |
| 42337227 | Beyond a waste product: lactate as a master metabolite dictating anti-tumor T-cell fate. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42337227 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| HCAR1 | 27198 | PubTator's text mining | https://conductscience.org/library/genes/27198 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| LDHA | 3939 | PubTator's text mining | https://conductscience.org/library/genes/3939 | NCBI Gene |
| LDHD | 197257 | PubTator's text mining | https://conductscience.org/library/genes/197257 | NCBI Gene |
| PDCD1 | 5133 | PubTator's text mining | https://conductscience.org/library/genes/5133 | NCBI Gene |
| TAFAZZIN | 6901 | PubTator's text mining | https://conductscience.org/library/genes/6901 | NCBI Gene |
| WWTR1 | 25937 | PubTator's text mining | https://conductscience.org/library/genes/25937 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28604752
GET https://conductscience.org/api/papers/v1/28604752/references?page=2